Literature DB >> 1826266

A transcriptional enhancer of the mouse T cell receptor delta gene locus.

L L Gill1, D Zaninetta, K Karjalainen.   

Abstract

T cells express receptors for antigen on their surface (TcR) which consists either of alpha/beta or of gamma/delta polypeptide chains. Since the TcR delta chain gene is located within the TcR alpha chain gene locus, strict regulation of expression of the region must operate to ensure that the two loci are not concomitantly expressed in T cells bearing either alpha/beta or gamma/delta TcR. In this report it is demonstrated that elements within the mouse TcR delta gene locus, located between the J delta 2 and C delta exons, enhance transcription from a heterologous promoter five- to tenfold in a T cell hybridoma expressing a TcR gamma/delta, whereas enhancement was only twofold in an alpha/beta-bearing T cell hybridoma. No enhancement of expression was observed in a B cell hybridoma. The sequences responsible for this enhancing activity are largely confined to a 766-bp Hae III DNA restriction fragment. A region within this DNA segment shows significant homology (73% identify) to a recently identified enhancer of the human TcR delta gene locus.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1826266     DOI: 10.1002/eji.1830210339

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  13 in total

Review 1.  Molecular regulation of cytokine gene expression during the immune response.

Authors:  J P Viola; A Rao
Journal:  J Clin Immunol       Date:  1999-03       Impact factor: 8.317

2.  T cell receptor (TCR) alpha/delta locus enhancer identity and position are critical for the assembly of TCR delta and alpha variable region genes.

Authors:  Craig H Bassing; Robert E Tillman; Barbara B Woodman; David Canty; Robert J Monroe; Barry P Sleckman; Frederick W Alt
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-25       Impact factor: 11.205

3.  Identification of an essential site for transcriptional activation within the human T-cell receptor delta enhancer.

Authors:  J M Redondo; J L Pfohl; M S Krangel
Journal:  Mol Cell Biol       Date:  1991-11       Impact factor: 4.272

Review 4.  Towards a comprehensive catalogue of validated and target-linked human enhancers.

Authors:  Molly Gasperini; Jacob M Tome; Jay Shendure
Journal:  Nat Rev Genet       Date:  2020-01-27       Impact factor: 53.242

5.  Enhancers as regulators of antigen receptor loci three-dimensional chromatin structure.

Authors:  E Mauricio Barajas-Mora; Ann J Feeney
Journal:  Transcription       Date:  2019-12-12

6.  An AML-1 consensus sequence binds an osteoblast-specific complex and transcriptionally activates the osteocalcin gene.

Authors:  C Banerjee; S W Hiebert; J L Stein; J B Lian; G S Stein
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

7.  Genomic structure around joining segments and constant regions of swine T-cell receptor alpha/delta (TRA/TRD) locus.

Authors:  Hirohide Uenishi; Hideki Hiraiwa; Ryuji Yamamoto; Hiroshi Yasue; Yohtaroh Takagaki; Takashi Shiina; Eri Kikkawa; Hidetoshi Inoko; Takashi Awata
Journal:  Immunology       Date:  2003-08       Impact factor: 7.397

8.  Identification of AML-1 and the (8;21) translocation protein (AML-1/ETO) as sequence-specific DNA-binding proteins: the runt homology domain is required for DNA binding and protein-protein interactions.

Authors:  S Meyers; J R Downing; S W Hiebert
Journal:  Mol Cell Biol       Date:  1993-10       Impact factor: 4.272

9.  Identification and characterization of an Alu-containing, T-cell-specific enhancer located in the last intron of the human CD8 alpha gene.

Authors:  J E Hambor; J Mennone; M E Coon; J H Hanke; P Kavathas
Journal:  Mol Cell Biol       Date:  1993-11       Impact factor: 4.272

10.  Regulation of the T-cell receptor delta enhancer by functional cooperation between c-Myb and core-binding factors.

Authors:  C Hernandez-Munain; M S Krangel
Journal:  Mol Cell Biol       Date:  1994-01       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.